Join to View Full Profile
1500 E Medical Center DrFl UnivAnn Arbor, MI 48109
Phone+1 734-936-4300
Dr. Wahl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganResidency, Radiation Oncology, 2012 - 2017
St Joseph Mercy Ann ArborInternship, Transitional Year, 2012 - 2013
University of Michigan Medical SchoolClass of 2012
Certifications & Licensure
MI State Medical License 2017 - 2027
American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Digital twins for in vivo metabolic flux estimations in patients with brain cancer.Baharan Meghdadi, Wajd N Al-Holou, Andrew J Scott, Anjali Mittal, Ningning Liang
Cell Metabolism. 2026-01-06 - 1 citationsAdaptive nuclear GTP synthesis promotes glioblastoma treatment resistance and is a targetable vulnerability in patients.Andrew J Scott, Ningning Liang, Wajd N Al-Holou, Jie Xu, Alexandra O'Brien
Medrxiv. 2025-11-13 - 1 citationsParotid-Sparing Versus Conventional Whole Brain Radiation Therapy: A Multi-Institutional Randomized Clinical Trial.Kyle Wang, Allison M Deal, Colette J Shen, Heather D Pacholke, Alexis Wardell
International Journal of Radiation Oncology, Biology, Physics. 2025-10-27
Journal Articles
- No Sugar Added: A New Strategy to Inhibit Glioblastoma Receptor Tyrosine KinasesDaniel R Wahl, Theodore S Lawrence, Clinical Cancer Research
Press Mentions
Starving Glioblastoma: Diet-Based Treatment Shows PromiseSeptember 8th, 2025- Small Lab Leans on Integrity to Become Nationally-Recognized Phenotyping CenterJune 8th, 2021
- Rackham Student Raises over $80,000 for University of Michigan NeurosurgeonMarch 15th, 2021
Grant Support
- New methods to measure and interrupt metabolic fluxes in brain cancerUNIVERSITY OF MICHIGAN AT ANN ARBOR2025–2029
- Inhibition of wild-type IDH1 as a ferroptosis-inducing therapeutic approach for the treatment of malignant glioma.WASHINGTON UNIVERSITY2022–2027
- Targeting Nucleotide Metabolism to Overcome Therapy Resistance in GlioblastomaUNIVERSITY OF MICHIGAN AT ANN ARBOR2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
